- Home
- PRO vs BBNX Comparison
PRO vs BBNX Comparison
Compare PRO & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRO
- BBNX
- Stock Information
- Founded
- PRO 1985
- BBNX 2015
- Country
- PRO United States
- BBNX United States
- Employees
- PRO N/A
- BBNX N/A
- Industry
- PRO EDP Services
- BBNX Medical/Dental Instruments
- Sector
- PRO Technology
- BBNX Health Care
- Exchange
- PRO Nasdaq
- BBNX Nasdaq
- Market Cap
- PRO 863.3M
- BBNX 649.9M
- IPO Year
- PRO 2007
- BBNX 2025
- Fundamental
- Price
- PRO $16.61
- BBNX $13.52
- Analyst Decision
- PRO Strong Buy
- BBNX Strong Buy
- Analyst Count
- PRO 10
- BBNX 10
- Target Price
- PRO $28.50
- BBNX $25.20
- AVG Volume (30 Days)
- PRO 1.2M
- BBNX 526.7K
- Earning Date
- PRO 07-29-2025
- BBNX 07-29-2025
- Dividend Yield
- PRO N/A
- BBNX N/A
- EPS Growth
- PRO N/A
- BBNX N/A
- EPS
- PRO N/A
- BBNX N/A
- Revenue
- PRO $336,006,000.00
- BBNX $69,830,000.00
- Revenue This Year
- PRO $10.25
- BBNX $32.79
- Revenue Next Year
- PRO $10.46
- BBNX $36.59
- P/E Ratio
- PRO N/A
- BBNX N/A
- Revenue Growth
- PRO 7.97
- BBNX 38911.17
- 52 Week Low
- PRO $13.61
- BBNX $8.89
- 52 Week High
- PRO $29.84
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- PRO 51.93
- BBNX N/A
- Support Level
- PRO $14.76
- BBNX N/A
- Resistance Level
- PRO $20.28
- BBNX N/A
- Average True Range (ATR)
- PRO 0.78
- BBNX 0.00
- MACD
- PRO 0.16
- BBNX 0.00
- Stochastic Oscillator
- PRO 77.92
- BBNX 0.00
About PRO PROS Holdings Inc.
Pros Holdings Inc provides software solutions that optimize shopping and selling experiences for both business-to-business and business-to-consumer companies across industry verticals in more than nearly 80 countries. Its PROS Platform is designed to help businesses create, optimize and market available offers and handle orders through both first- and third-party digital channels. The firm generates key revenue form the United States of America, Germany, The rest of Europe, Africa, Asia-Pacific, and Middle East regions.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.